Legend Biotech (LEGN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LEGN Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Legend Biotech adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents901.90
Cash & Short-term Investments901.00
Accounts receivable13.10
Inventories32.00
Other Current Assets300.10
Total Current Assets1,247.10
Equipment/Property/Plant Net116.30
Intangible Assets1.90
Tax Assets, Noncurrent20.20
Other Assets, Noncurrent370.30
Total Assets1,733.70
Liabilities
Current Tax Liabilities19.20
Longterm Borrowings0.00
Other Liabilities, Current617.20
Total Current Liabilities636.40
Long-term debt8.00
Total Long-term Debt8.00
Accrued Income Taxes, Noncurrent20.20
Other liabilities, Noncurrent87.20
Total Liabilities731.60
Stockholders' Equity
Other Equity1,002.10
Common Stockholder's Equity1,002.10
Total Stockholder's Equity1,002.10
Liabilities & Stockholder's Equity1,733.70
4 historic quarters locked

Sign in to unlock the full Legend Biotech balance sheet history.

About Legend Biotech Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001801198-26-000008

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.